Navigation Links
Certain COPD Meds Linked to Urinary Troubles in Men
Date:5/23/2011

MONDAY, May 23 (HealthDay News) -- New research suggests that a certain class of drugs used to treat chronic obstructive pulmonary disease (COPD) boosts the risk that male patients will be unable to urinate.

The disease, which makes breathing difficult due to inflammation and blockage in the body's air passages, affects an estimated 10 percent of people aged 40 and older.

A class of drugs called "inhaled anticholinergic" medications are used to treat the conditions, but there are concerns about their side effects. These drugs include tiotropium (Spiriva), ipratropium bromide (brand name Atrovent) or Combivent, which is ipratropium combined with albuterol.

In the new Canadian study, Dr. Anne Stephenson of St. Michael's Hospital in Toronto and colleagues examined medical records from people in Ontario, aged 66 and older, who suffered from chronic obstructive pulmonary disease.

Of the more than 565,000 patients studied, 9,432 men and 1,806 women developed an inability to urinate. Among men, the researchers found a statistically significant link between those who took the drugs and those who didn't. Among those taking the drugs, the odds of the urinary condition were about 40 percent higher in those who'd been using the drugs for 4 weeks or less, and they were 80 percent higher among those with enlarged prostate glands.

"Physicians should highlight for patients the possible connection between urinary symptoms and inhaled respiratory medication use to ensure that changes in urinary flow (i.e., incomplete voiding, urinary incontinence, and decreased urinary flow) are reported to the physician," the authors wrote.

The researchers added that low doses of the drugs may reduce a patient's risk for these urinary problems.

The study is published in the May 23 issue of the Archives of Internal Medicine.

More information

To find out more about the treatment of COPD, head to the U.S. National Heart, Lung, and Blood Institute.

-- Randy Dotinga

SOURCE: JAMA/Archives, news release, May 23, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Increase in risk of certain gastric cancer from heavy drinking
2. After Heart Attack, Certain Painkillers May Raise Risk for Recurrence
3. Researchers discover mechanism that could convert certain cells into insulin-making cells
4. Heart attacks are more serious if they occur at certain times of the day
5. Certain Genes Could Add to Alcoholism Risk
6. Prenatal exposure to certain pollutants linked to behavioral problems in young children
7. Parkinsons May Have Links to Certain Cancers, Study Suggests
8. Certain Diabetes Drugs Better for Heart Health, Study Finds
9. Progesterone Treatment Cuts Preterm Birth Risk in Certain Women
10. Certain breast cancer patients worry excessively about recurrence
11. Study Questions Rise in Use of Certain Cholesterol Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Certain COPD Meds Linked to Urinary Troubles in Men
(Date:1/23/2020)... ... January 23, 2020 , ... ... memory impairment, has announced the Best Memory Care Facilities in Pensacola, Florida. The ... features and amenities. , According to the Alzheimer’s Association , 5.6 ...
(Date:1/23/2020)... ... January 23, 2020 , ... FEI Behavioral Health, a ... workforce resilience, is presenting at the NATSAP 2020 Conference. , NATSAP, The National ... organizations that devote themselves to society’s need for the effective care and education ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... Dr. Dan ... to become a new member of their professional dental staff. The Dentist ... general dentistry, cosmetic dentistry, emergency dentistry and restorative dentistry, all in a ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... SaaS vendor announced their partner agreement with Healthpac, a trusted medical billing ... offices and medical offices an expanded offering. Healthpac’s customers can now access ...
(Date:1/23/2020)... ... January 23, 2020 , ... The Incentive Research Foundation is ... Trustees. Representing all segments of the incentives, rewards, and recognition industry, the IRF ... and providing education highlighting the power of incentive and motivational programs. The Board ...
Breaking Medicine News(10 mins):
(Date:1/22/2020)... BRUNSWICK, N.J. (PRWEB) , ... January 22, 2020 , ... ... Patent (US 10,500,240) on Terminalia chebula. This newly granted patent expands Natreon’s strong patent ... trials. , The primary claim in this patent is, “a method of treating ...
(Date:1/12/2020)... ... 2020 , ... FutuRx, Israel’s leading biopharmaceutical incubator, a partnership ... Inc, operating under a tender from the Israeli Innovation Authority (IIA) has recently ... Tel-Aviv University and Glasgow University. , Epeius pharma develops next generation biological ...
(Date:1/10/2020)... ... 10, 2020 , ... Mymee, a digital care program aimed at solving the ... new website features real client success stories, a simplified description of how the ... self-insured employers and payers. , “There were two key drivers in reimagining the ...
Breaking Medicine Technology: